胃肠道间质瘤的治疗研究进展
Research Progress in the Treatment of Gastrointestinal Stromal Tumors
DOI: 10.12677/ACM.2023.1392066, PDF,   
作者: 金 龙, 王 强:内蒙古民族大学第二临床附属医院,内蒙古 通辽
关键词: 胃肠道间质瘤开放手术内镜治疗化疗Gastrointestinal Stromal Tumors Open Surgery Endoscopic Treatment Chemotherapy
摘要: 胃肠道间质瘤是起源于卡哈尔氏(Cajal)间质细胞的软组织。这类神经细胞与食物消化过程中的肠道运动相关。可发生于全消化道,最常见部位是胃和小肠,也可发生于胃肠道外网膜及肠系膜处。生物学行为上可以从良性到恶性。大部分的GIST (直径小于2 cm)和小的GIST (直径小于1 cm)是良性的。根据病人的具体情况,选择合适的治疗方法,达到最大程度的治愈效果。目前以手术为主,化疗为主。该文综述了当前关于GIST的认识与处理方法,并着重阐述了近年来的研究进展。
Abstract: Gastrointestinal stromal tumors are soft tissues originating from Cajal’s interstitial cells. These types of nerve cells are associated with intestinal motility during food digestion. It can occur in the entire digestive tract, with the most common sites being the stomach and small intestine, as well as in the external omentum and mesentery of the gastrointestinal tract. Biological behavior can range from benign to malignant. Most GIST (diameter less than 2 cm) and small GIST (diameter less than 1 cm) are benign. Choose appropriate treatment methods based on the specific situation of the pa-tient to achieve the maximum healing effect. At present, surgery is the main method, while chemo-therapy is the main method. This article reviews the current understanding and processing meth-ods of GIST, and focuses on the research progress in recent years.
文章引用:金龙, 王强. 胃肠道间质瘤的治疗研究进展[J]. 临床医学进展, 2023, 13(9): 14769-14775. https://doi.org/10.12677/ACM.2023.1392066

参考文献

[1] Schmidt, T., Ghadimi, M., Fuchs, H.F. and Bruns, C.J. (2022) Chirurgische und interdisziplinäre Therapie gastrointesti-naler Stromatumoren [Surgical and Interdisciplinary Treatment of Gastrointestinal Stromal Tumors]. Der Chirurg, 93, 27-33. (In German) [Google Scholar] [CrossRef] [PubMed]
[2] Schaefer, I.M., DeMatteo, R.P. and Serrano, C. (2022) The GIST of Advances in Treatment of Advanced Gastrointestinal Stromal Tumor. American Society of Clini-cal Oncology Educational Book, 42, 885-899. [Google Scholar] [CrossRef
[3] Wang, Y., Bai, G., Zhang, H. and Chen, W. (2023) Simple Scoring Model Based on Enhanced CT inPreoperative Prediction of Biological Risk of Gastrointestinal Stromal Tumor. Technol-ogy in Cancer Research & Treatment, 22, Article ID: 15330338231194502. [Google Scholar] [CrossRef] [PubMed]
[4] Akahoshi, K., Oya, M., Koga, T. and Shiratsuchi, Y. (2018) Current Clinical Management of Gastrointestinal Stromal Tumor. World Journal of Gastroenterology, 24, 2806-2817. [Google Scholar] [CrossRef] [PubMed]
[5] Miettinen, M. and Lasota, J. (2013) Gastrointestinal Stromal Tumors. Gastroenterology Clinics of North America, 42, 399-415. [Google Scholar] [CrossRef] [PubMed]
[6] Nishida, T., Blay, J.Y., Hirota, S., Kitagawa, Y. and Kang, Y.-K. (2016) The Standard Diagnosis, Treatment, and Follow-up of Gastrointestinal Stromal Tumors Based on Guidelines. Gastric Cancer, 19, 3-14. [Google Scholar] [CrossRef] [PubMed]
[7] Du, H., Ning, L., Li, S., Lou, X., Chen, H., Hu, F., Shan, G., Zhang, F. and Xu, G. (2020) Diagnosis and Treatment of Duodenal Gastrointestinal Stromal Tumors. Clinical and Translational Gastroenterology, 11, e00156. [Google Scholar] [CrossRef] [PubMed]
[8] 赵文毅, 赵刚, 汪明. 美国国家综合癌症网络软组织肉瘤临床实践指南(2019年第6版)胃肠间质瘤内容介绍与更新解读[J].中华胃肠外科杂志, 2020, 23(9): 866-871. [Google Scholar] [CrossRef] [PubMed]
[9] Li, J., Ye, Y., Wang, J., Zhang, B., Qin, S., Shi, Y., He, Y., Liang, X., Liu, X., Zhou, Y., Wu, X., Zhang, X., Wang, M., Gao, Z., Lin, T., Cao, H. and Shen, L. (2017) Chi-nese Consensus Guidelines for Diagnosis and Management of Gastrointestinal Stromal Tumor. Chinese Journal of Can-cer Research, 29, 281-293. [Google Scholar] [CrossRef] [PubMed]
[10] Casali, P.G., Abecassis, N., Aro, H.T., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J.V.M.G., Brodowicz, T., Broto, J.M., Buonadonna, A., De Álava, E., DeiTos, A.P., Del Muro, X.G., Dileo, P., Eriksson, M., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A.M., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A,, Haas, R.L., Hassan, B., Hohenberger, P., Issels, R., Joensuu, H., Jones, R.L., Judson, I., Jutte, P., Kaal, S., Kasper, B., Kopeckova, K., Krákorová, D.A., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Pantaleo, M.A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A.L., Reichardt, P., Robinson, M.H., Rutkowski, P., Safwat, A.A., Schöffski, P., Sleijfer, S., Stacchiotti, S., Sundby Hall, K., Unk, M., Van Coevorden, F., van der Graaf, W.T.A., Whelan, J., Wardelmann, E., Zaikova, O. and Blay, J.Y. (2018) Corrections to “Gastrointestinal Stromal Tumours: ESMO-EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up”. Annals of Oncology, 29, iv267. [Google Scholar] [CrossRef] [PubMed]
[11] 中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)胃肠间质瘤诊疗指南2020 [M]. 北京: 人民卫生出版社, 2020.
[12] 汪明, 曹晖. 从2020年国内外主要指南更新变化解读胃肠间质瘤精准诊治[J]. 中国实用外科杂志, 2021, 41(2): 125-129. 02.02 [Google Scholar] [CrossRef
[13] 中华医学会消化内镜学分会消化内镜隧道技术协作组, 中国医师协会内镜医师分会, 北京医学会消化内镜学分会. 中国胃肠间质瘤内镜下诊治专家共识(2020, 北京) [J]. 中华消化内镜杂志, 2021, 38(7): 505-514. [Google Scholar] [CrossRef
[14] Du, C.-Y., Zhou, Y., Song, C., et al. (2014) Is There a Role of Surgery in Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumours Responding to Imatinib: A Prospective Randomised Trial in China. European Journal of Cancer, 50, 1772-1778. [Google Scholar] [CrossRef] [PubMed]
[15] Sun, Y., Liu, L., Shi, D., Ma, C. and Xu, X. (2023) Assessment of a Real-World Learning Curve for the Endoscopic Resection of Gastric Gastrointestinal Stromal Tumors. Journal of In-ternational Medical Research, 51. [Google Scholar] [CrossRef] [PubMed]
[16] Huang, C.M., Chen, Q.-F., Lin, J.-X., et al. (2017) Can Lapa-roscopic Surgery Be Applied in Gastric Gastrointestinal Stromal Tumors Located in Unfavorable Sites?: A Study Based on the NCCN Guidelines. Medicine, 96, e6535. [Google Scholar] [CrossRef
[17] Joensuu, H., Wardelmann, E., Sihto, H., Eriksson, M., Sundby Hall, K., Reichardt, A., Hartmann, J.T., Pink, D., Cameron, S., Hohenberger, P., Al-Batran, S.E., Schlemmer, M., Bauer, S., Nilsson, B., Kallio, R., Junnila, J., Vehtari, A. and Reichardt, P. (2017) Effect of KIT and PDGFRA Mu-tations on Survival in Patients with Gastrointestinal Stromal Tumors Treated with Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial. JAMA Oncology, 3, 602-609. [Google Scholar] [CrossRef] [PubMed]
[18] Iwatsuki, M., Harada, K., Iwagami, S., Eto, K., Ishimoto, T., Baba, Y., Yoshida, N., Ajani, J.A. and Baba, H. (2019) Neoadjuvant and Adjuvant Therapy for Gastrointestinal Stromal Tumors. Annals of Gastroenterological Surgery, 3, 43-49. [Google Scholar] [CrossRef] [PubMed]
[19] Jakob, J. and Hohenberger, P. (2018) Neoadjuvant Therapy to Downstage the Extent of Resection of Gastrointestinal Stromal Tumors. Visceral Medicine, 34, 359-365. [Google Scholar] [CrossRef] [PubMed]
[20] Nishida, T., Doi, T. and Naito, Y. (2014) Tyrosine Kinase Inhibitors in the Treatment of Unresectable or Metastatic Gastrointestinal Stromal Tumors. Expert Opin-ion on Pharmacotherapy, 15, 1979-1989. [Google Scholar] [CrossRef] [PubMed]
[21] Demetri, G.D., Reichardt, P., Kang, Y.K., Blay, J.Y., Rutkowski, P., Gelderblom, H., Hohenberger, P., Leahy, M., von Mehren, M., Joensuu, H., Badalamenti, G., Blackstein, M., Le Cesne, A., Schöffski, P., Maki, R.G., Bauer, S., Nguyen, B.B., Xu, J., Nishida, T., Chung, J., Kappeler, C., Kuss, I., Laurent, D. and Casali, P.G. (2013) Efficacy and Safety of Regorafenib for Advanced Gastrointestinal Stromal Tu-mours after Failure of Imatinib and Sunitinib (GRID): An International, Multicentre, Randomised, Placebo-Controlled, Phase 3 Trial. Lancet, 381, 295-302. [Google Scholar] [CrossRef
[22] Blay, J.Y., Bonvalot, S., Casali, P., Choi, H., Debiec-Richter, M., Dei Tos, A.P., Emile, J.F., Gronchi, A., Hogendoorn, P.C., Joensuu, H., Le Cesne, A., McClure, J., Maurel, J., Nupponen, N., Ray-Coquard, I., Reichardt, P., Sciot, R., Stroobants, S., van Glabbeke, M., van Oosterom, A., Demetri, G.D. and GIST Consensus Meeting Panelists (2005) Consensus Meeting for the Management of Gastrointestinal Stro-mal Tumors Report of the GIST Consensus Conference of 20-21 March 2004, under the Auspices of ESMO. Annals of Oncology, 16, 566-578. [Google Scholar] [CrossRef] [PubMed]